These compounds may interact with:

COUP transcription factor 2

Potentially involved in: carcinoma; congenital diaphragmatic hernia; autosomal dominant nonsyndromic deafness 15; congenital heart disease; cancer; aortic coarctation; aortic valve stenosis; endocardial cushion defects; endometriosis; heart septal defects; ventricular septal defects; diaphragmatic hernia; female infertility; tetralogy of fallot; hypoplastic left heart syndrome; common atrioventricular canal; partial atrioventricular canal; complete atrioventricular septal defect; atrioventricular canal defect; congenital heart defects, multiple types, 4

Disease data sourced from Pharos.